Integrated filing (Financial) for the quarter and year ended 31.03.2025
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Albert David Limited reported a sharp decline in full-year FY25 performance, with revenue from operations falling about 4.6% to Rs 34,576.8 Lacs from Rs 36,246.2 Lacs in FY24. Profit after tax plunged roughly 77% to Rs 1,720.1 Lacs from Rs 7,542 Lacs, dragging EPS down to Rs 30.14 from Rs 132.15. The fourth quarter was particularly weak, with the company slipping into a loss of Rs 1,032.8 Lacs versus a profit of Rs 1,291.3 Lacs in Q4 FY24, as total income for the quarter dropped to Rs 6,977.9 Lacs. The Board has recommended a dividend of Rs 5 per share, and the statutory auditor (M/s L.B. Jha & Co.) issued an unmodified opinion. Operating cash flow turned negative at Rs -2,843.6 Lacs against Rs +4,550.2 Lacs last year, mainly due to higher inventory build-up and lower profits.
Shareholders should brace for negative near-term sentiment given the steep fall in profits, quarterly loss, and negative operating cash flow, though the dividend and clean audit opinion offer some comfort. The weak quarterly performance and margin compression are likely to weigh on the stock in the short term.